One of the nation’s leading cancer research and treatment centers, the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center located in a six-state area. UAB’s cancer services are routinely recognized as being among the nation’s best. From bench to bedside, the UAB Comprehensive Cancer Center is at the forefront of improving cancer prevention, diagnosis, and treatment, and researchers here have pioneered advances in chemotherapy, surgery, radiotherapy, immunotherapy, and nutrition. The UAB Comprehensive Cancer Center is recognized around the world as a leader in developing innovative monoclonal antibody approaches to cancer therapy. The Center conducts clinical trials using genetically engineered monoclonal antibodies alone or armed with a payload of immunotoxins, chemotherapy drugs, or radioactive isotopes to specifically target a broad array of cancers, including breast, gastrointestinal tract, lung, ovary, head and neck, brain tumors, and lymphomas.
Enhancing research and treatment in gastrointestinal malignancies is an institutional priority at UAB. The multidisciplinary Gastrointestinal Oncology Clinic treats all types of gastrointestinal malignancies, and identifies candidates for clinical trials. Several investigators within the comprehensive cancer center have well established laboratory research programs in gastrointestinal malignancy, and the cancer center has held a pancreatic cancer SPORE.
The Director of the Gastrointestinal Oncology Program will be an outstanding academic physician investigator with expertise in the care of gastrointestinal malignancies, and with the ability and personal characteristics to direct the development of an outstanding interdisciplinary clinical gastrointestinal oncology program. The role of the Director is to build, maintain, and continually improve an outstanding academic program for the care of patients with gastrointestinal malignancies, and for those who work and learn within the program. The Director of the Gastrointestinal Oncology Program will be engaged and committed to the development of a premier facility which provides exemplary care for patients in a comprehensive, cohesive, efficient and integrated manner. An important goal and a top immediate priority is to provide outstanding and accessible care to patients with gastrointestinal malignancies. To facilitate gastrointestinal oncology clinical trials, the Director will lead the GI oncology clinical trials clinical trials team, including research nurses and data managers, within the framework of Clinical Studies Unit.
UAB will invest substantially in the success of the Director, and will build on initial commitments as he/she achieve success over time. UAB is committed to recruiting at least two more Gastrointestinal Oncology physicians, with further physician recruitment supported by programmatic growth and strategic requirements and opportunities. The Gastrointestinal Oncology program is supported by a nurse practitioner with additional staffing following UABHSF guidelines for support of clinical practices.
- An MD or MD/PhD degree.
- Eligibility for Alabama licensure as a medical doctor.
- An academic rank of associate of full professor.
- Board certification in Internal Medicine and Medical Oncology, specialized expertise in gastrointestinal oncology.
- Strong leadership skills with the ability to advance and develop a superior clinical service.
- Experience and expertise in research including Phase 1 and early Phase II clinical trials.
- Excellent interpersonal communication and presentation skills for both clinical and non-clinical audiences, in group settings or one-on-one.
- Expertise in establishing physician relationships combined with the ability to manage an interdisciplinary team while appreciating and fostering collegial and peer participation from all disciplines.
- Effective supervisory skills, including clinical mentoring and coaching expertise.
- Advocate for organizational values and commitment to gender equity and diversity.
- Demonstrated experience with capital/operating budgets and an understanding of the challenges facing academic medicine.